Zimmer Biomet Holdings (NYSE: ZBH) reported Q2 EPS of $1.82, $0.01 better than the analyst estimate of $1.81. Revenue for the quarter came in at $1.87 billion versus the consensus estimate of $1.82 billion.

Guidance:

Adjusted Diluted EPS in the range of $7.47 - $7.57

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.